B Abrahamsen
Copenhagen, Denmark
Tue 20 09:15
CM2.3
Clinical Management Workshop 2: CONTROVERSIES IN AETIOLOGY AND MANAGEMENT OF OSTEOPOROSIS
Complications of antiresorptive agents
Copenhagen, Denmark
R Ajjan
Wed 21 09:00
N1.1
Nurses' Session 1:
Thyroid Eye Disease - presentation and treatment
A Allahabadia
Wed 21 07:15
MTE4
MEET THE EXPERT 4
Management of persistent TSH elevation in hypothyroid patients
Thu 22 12:30
MTE4
MEET THE EXPERT 4 - REPEAT
Management of persistent TSH elevation in hypothyroid patients
R Allemann
Wed 21 13:45
MTE8
MEET THE EXPERT 8
Optogenetics: controlling cells with light
D Anderson
Montecastello di Vibio, Italy
Thu 22 12:35
SE1.6
SENIOR ENDOCRINOLOGISTS' SESSION
Psychopathology of false conviction
Montecastello di Vibio, Italy
J Arendt
Tue 20 14:30
S7.2
Symposium 7: LATITUDE: ENDOCRINE CONSEQUENCES OF HUMAN MIGRATION
Melatonin, light and sleep in the Antartic
W Arlt
Tue 20 07:15
MTE1
MEET THE EXPERT 1
Therapeutic management of adults with CAH
Tue 20 16:30
MTE1
MEET THE EXPERT 1 - REPEAT
Therapeutic management of adults with CAH
C Barratt
Thu 22 11:00
CM3.2
Clinical Management Workshop 3: ADVANCES IN ASSESSMENT AND MANAGEMENT OF INFERTILITY
Semen analysis: what does it mean and can we improve it?
R Bernhardt
Saarbrucken, Germany
Tue 20 08:45
S6.2
Symposium 6: INHIBITING STEROID ENZYMES TO TREAT COMMON DISEASE
Old drugs for new targets - CYP11B2 inhibitors for hypertension
Saarbrucken, Germany
S Bhasin
Boston, USA
Mon 19 11:30
S3.2
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Does testosterone treatment increase mortality in elderly men?
Boston, USA
N Bishop
Tue 20 08:45
CM2.2
Clinical Management Workshop 2: CONTROVERSIES IN AETIOLOGY AND MANAGEMENT OF OSTEOPOROSIS
Osteoporosis and metabolic bone disease in adolescence
P Bouloux
Mon 19 12:00
S3.3
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
What is the best form of testosterone replacement?
S Bouret
Los Angeles, USA
Wed 21 09:30
S9.2
Symposium 9: DEVELOPMENTAL PROGRAMMING OF ENDOCRINE DISEASE
Neuroendocrine origins of obesity
Los Angeles, USA
G Brabant
Mon 19 17:30
CM1.4
Clinical Management Workshop 1: THE LATE CONSEQUENCES OF CANCER THERAPY IN ADULTS
The late consequences of cancer therapy to the thyroid
F Broekmans
Utrecht, The Netherlands
Thu 22 11:30
CM3.3
Clinical Management Workshop 3: ADVANCES IN ASSESSMENT AND MANAGEMENT OF INFERTILITY
How can we predict ovarian reserve and how useful is this?
Utrecht, The Netherlands
M Bushall
Tue 20 16:30
S8.1
Symposium 8: SMALL MOLECULES, BIG EFFECTS: THE EMERGING ROLE FOR MICRO RNAS
MicroRNA: an introduction
J Carroll
Wed 21 14:45
MTE9
MEET THE EXPERT 9
All you need to know about CHIP-sequencing
A Clow
Tue 20 15:00
S7.3
Symposium 7: LATITUDE: ENDOCRINE CONSEQUENCES OF HUMAN MIGRATION
Cortisol and mood - coping with seasons
M Cnop
Brussels, Belgium
Mon 19 12:00
S2.3
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
Lipotoxic endoplasmic reticulum stress and pancreatic beta-cell demise in type 2 diabetes
Brussels, Belgium
J Connell
Wed 21 15:15
S11.4
Symposium 11: NOVEL LESSONS FROM MINERALOCORTICOID EXCESS
Therapeutic options for mineralocorticoid hypertension
B Cooke
Thu 22 10:30
SE1.1
SENIOR ENDOCRINOLOGISTS' SESSION
Seeing the light
I Cooke
Thu 22 11:45
SE1.4
SENIOR ENDOCRINOLOGISTS' SESSION
Assisted conception and developing low cost version for the developing world
M Cooper
Tue 20 08:15
S6.1
Symposium 6: INHIBITING STEROID ENZYMES TO TREAT COMMON DISEASE
Ageing gracefully - the role of 11beta-HSD1
P Dahia
San Antonio, USA
Wed 21 09:30
S10.2
Symposium 10:
Molecular mechanisms of phaeochromocytoma and tumorigenesis
San Antonio, USA
H Dawson-Smith
Wed 21 15:15
N2.5
Nurses' Session 2:
Living with Addison's
S Driesche
Tue 20 15:00
OC4.5
Oral Communications 4: Steroids
A novel repressor mechanism regulating fetal Leydig cell steroidogenesis, pertubation of which results in masculinization disorders
C Duncan
Thu 22 07:30
MTE7
MEET THE EXPERT 7
Regulating periods and optimising fertility in PCOS
Thu 22 13:15
MTE7
MEET THE EXPERT 7 - REPEAT
Regulating periods and optimising fertility in PCOS
R Eastell
Tue 20 09:45
CM2.4
Clinical Management Workshop 2: CONTROVERSIES IN AETIOLOGY AND MANAGEMENT OF OSTEOPOROSIS
New and emerging therapies for osteoporosis
C Edwards
Thu 22 12:10
SE1.5
SENIOR ENDOCRINOLOGISTS' SESSION
Tales from an arthritic endocrinologist - why does the endocrine dog not bark in the cytokine night?
S Farooqi
Wed 21 17:15
PL7
SOCIETY FOR ENDOCRINOLOGY MEDAL LECTURE
Genetic, molecular and physiological mechanisms involved in human obesity
F Farrokhnia
Mon 19 17:15
OC2.6
Oral Communications 2: REPRODUCTION AND BONE
Identification of microRNAs involved in regulating growth factor signalling in the first trimester placenta
Dr Karen Forbes
Leeds, UK
Tue 20 14:00
YE1.1
Young Endocrinologists' Symposium: OBTAINING FUNDING AND NETWORKING FOR YOUNG ENDOCRINOLOGISTS
Obtaining fellowship funding and networking
Leeds, UK
Tue 20 17:00
S8.2
Symposium 8: SMALL MOLECULES, BIG EFFECTS: THE EMERGING ROLE FOR MICRO RNAS
MicroRNA regulation of the IGF axis
Leeds, UK
S Ford
Laramie, USA
Wed 21 10:30
S9.4
Symposium 9: DEVELOPMENTAL PROGRAMMING OF ENDOCRINE DISEASE
Obesity in pregnancy: implications for the next generation
Laramie, USA
P Foster
Tue 20 09:15
S6.3
Symposium 6: INHIBITING STEROID ENZYMES TO TREAT COMMON DISEASE
Dual aromatase and steroid sulfatase inhibition in breast cancer
R Fowkes
Tue 20 15:30
YE1.4
Young Endocrinologists' Symposium: OBTAINING FUNDING AND NETWORKING FOR YOUNG ENDOCRINOLOGISTS
Trials and tribulations of the university lecturer
J Franklyn
Wed 21 16:45
PL6
BRITISH THYROID ASSOCIATION PITT-RIVERS LECTURE
The thyroid - too much and too little across the ages
L Gathercole
Mon 19 18:10
YEP1.1
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Challenging the dogma: Tissue specific regulation of insulin action
J George
Mon 19 13:30
OC1.1
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Functional characterisation and translational clinical applications of kisspeptin-10
A Gogakos
Mon 19 14:00
OC1.3
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Effect of selenium status on the skeleton in post-menopausal women: the OPUS study
D Greenfield
Mon 19 16:00
CM1.1
Clinical Management Workshop 1: THE LATE CONSEQUENCES OF CANCER THERAPY IN ADULTS
The follow up of cancer survivors
F Hannan
Mon 19 13:45
OC1.2
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Structure-function analysis of calcium-sensing receptor (CaSR) mutations reveal clustering at calcium binding sites of the extracellular bilobed venus flytrap domain
Mon 19 17:45
OC2.8
Oral Communications 2: REPRODUCTION AND BONE
A calcium-sensing receptor (CaSR) variant, Glu250Lys, present in familial hypocalciuric hypercalcaemia (FHH) and autosomal dominant hypocalcaemic hypercalciuria (ADHH) probands represents a functionally neutral polymorphism: lessons for CaSR mutational analysis
D Hanson
Tue 20 16:30
OC5.1
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
Human growth is regulated by an ubiquitination pathway including CUL7, OBSL1 and CCDC8
B Harrison
Sheffield, UK
Wed 21 07:15
MTE5
MEET THE EXPERT 5
The surgical approaches to MEN1 - what the endocrinologist needs to know
Sheffield, UK
Thu 22 12:30
MTE5
MEET THE EXPERT 5 - REPEAT
The surgical approaches to MEN1 - what the endocrinologist needs to know
Sheffield, UK
A Harte
Tue 20 08:30
OC3.2
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Post-prandial high fat intake leads to acute exposure to circulating endotoxin in type 2 diabetes mellitus subjects
A Hattersley
Mon 19 12:30
S2.4
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
Patients with monogenic diabetes resulting from ER stress of the pancreatic beta-cell
I Hay
Rochester, USA
Mon 19 14:30
S4.3
Symposium 4: ADVANCES IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER
The place of radioiodine in the management of thyroid cancer
Rochester, USA
J Hazlehurst
Tue 20 15:30
OC4.7
Oral Communications 4: Steroids
Glucocorticoids increase subcutaneous adipose tissue insulin sensitivity in vivo: a randomised double-blind, placebo controlled, cross over study
G Hervey
Thu 22 10:55
SE1.2
SENIOR ENDOCRINOLOGISTS' SESSION
It's time to identify the hormone that maintains bodty fat content
M Holmes
Wed 21 10:00
S9.3
Symposium 9: DEVELOPMENTAL PROGRAMMING OF ENDOCRINE DISEASE
The foetus or the placenta? Targets of glucorticoid programming
T Howlett
Tue 20 18:15
OC5.8
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
Control of GH and IGF1 in acromegaly in the UK: responses to medical treatment
Wed 21 14:30
N2.3
Nurses' Session 2:
Introduction to Addison's
J Idkowiak
Tue 20 14:45
OC4.4
Oral Communications 4: Steroids
Broad phenotypic spectrum of 17a-hydroxylase deficiency: functional characterisation of 4 novel mutations in the CYP17A1 gene
P Igaz
Tue 20 18:00
S8.4
Symposium 8: SMALL MOLECULES, BIG EFFECTS: THE EMERGING ROLE FOR MICRO RNAS
MicroRNA in the diagnosis and therapy of endcorine cancers
M Jangani
Mon 19 15:15
OC1.8
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Metastasis related methyltransferase 1 (Merm1)/WBSCR22 regulates glucocorticoid receptor (GR) function
C Jayasena
Mon 19 16:15
OC2.2
Oral Communications 2: REPRODUCTION AND BONE
Contrasting effects of kisspeptin-10 between men and women reveal sexual dimorphism in the hypothalamic regulation of human reproduction
H Jones
Thu 22 11:50
CM4.5
Clinical Management Workshop 4: HOW DO I APPROACH...
Hypogonadism in a man with cancer of the prostate
J Juul-Holst
Copenhagen, Denmark
Wed 21 11:30
PL4
SOCIETY FOR ENDOCRINOLOGY EUROPEAN MEDAL LECTURE
GLP-1 therapy of type 2 diabetes - current status
Copenhagen, Denmark
G Karsenty
New York, USA
Tue 20 11:20
PL2
SOCIETY FOR ENDOCRINOLOGY HOFFENBERG INTERNATIONAL MEDAL LECTURE
Bone as endocrine organ
New York, USA
T Kearney
Thu 22 10:30
CM4.1
Clinical Management Workshop 4: HOW DO I APPROACH...
Drug-induced hyperprolactinaemia
D Kendall
Tue 20 08:15
OC3.1
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Metformin in obese children and adolescents (MOCA) trial
J Kirk
Birmingham, UK
Thu 22 12:10
CM4.6
Clinical Management Workshop 4: HOW DO I APPROACH...
Endocrine evaluation in a patient with iron overload
Birmingham, UK
Dr Kenneth Korach
Durham, USA
Tue 20 10:40
PL1
SOCIETY FOR ENDOCRINOLOGY DALE MEDAL LECTURE
Estrogen receptor insensitivity: physiological and clinical consequences
Durham, USA
Márta Korbonits
Mon 19 12:30
S1.4
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Molecular signatures of pituitary tumours
J Kowalczyk
Mon 19 14:45
OC1.6
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
A homozygous glutathione peroxidase 1 mutation, p.Arg130-Leu133del, in a patient with familial glucocorticoid deficiency
T Kurzawinski
Wed 21 14:45
S12.3
Symposium 12: MEDULLARY THYROID CANCER
The diagnosis and management of MTC
G Lanza
St Louis, USA
Mon 19 14:10
AP1.2
Applied Physiology Workshop:
Nanoparticles as imaging agents
St Louis, USA
V Leite
Lisbon, Portugal
Wed 21 14:15
S12.2
Symposium 12: MEDULLARY THYROID CANCER
RAS mutations in sporadic MTC
Lisbon, Portugal
N-A Liu
Los Angeles, USA
Mon 19 11:30
S1.2
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Modelling pituitary tumours in zebrafish
Los Angeles, USA
A Madathil
Tue 20 09:45
OC3.7
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Subclinical hypothyroidism is associated with fatigue and impaired functional status in males in the Whickham 20-year follow up cohort
E Maher
Wed 21 09:00
S10.1
Symposium 10:
Genetics and epidemiology
H Mani
Mon 19 17:30
OC2.7
Oral Communications 2: REPRODUCTION AND BONE
Increased cardiovascular events in women with polycystic ovary syndrome: retrospective analysis of a large database
V Marion
Strasbourg, France
Tue 20 09:00
OC3.4
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Glucose absorption capacity of the mature adipose tissue is increased after Bardet-Biedl syndrome induced ciliary defect in adipocytes' precursors
Strasbourg, France
J Martinez-Barbera
Mon 19 12:00
S1.3
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Mouse model of craniopharyngioma
K McInnes
Tue 20 15:15
OC4.6
Oral Communications 4: Steroids
Fatty liver in a mouse model of congenital adrenal hyperplasia is driven by peroxisome proliferator-activated receptors
J McLaren
Wed 21 10:30
N1.3
Nurses' Session 1:
Thyroid Eye Disease
K Meeran
Tue 20 07:15
MTE3
MEET THE EXPERT 3
Preventing and managing long term complications of acromegaly
Thu 22 12:30
MTE3
MEET THE EXPERT 3 - REPEAT
Preventing and managing long term complications of acromegaly
B Mendoca
Sao Paulo, Brazil
Thu 22 09:00
PL9
CLINICAL ENDOCRINOLOGY TRUST VISITING PROFESSOR LECTURE
Long-term outcome and quality of life in patients with disorders of sex development
Sao Paulo, Brazil
N Milton
Mon 19 16:30
OC2.3
Oral Communications 2: REPRODUCTION AND BONE
Kissorphin, a hexapeptide derivative of kisspeptin, acts via neuropeptide FF receptors to inhibit cyclic adenosine monophosphate release but has no gonadotrophin-releasing hormone releasing activity
S Mirczuk
Tue 20 17:45
OC5.6
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
SUMOylation genes in pituitary gonadotrophs: wrestling with GnRH signalling
A Mitchell
Tue 20 09:30
OC3.6
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
GATA3 polymorphisms are associated with autoimmune Addison's disease
C Moran
Cambridge
Mon 19 14:15
OC1.4
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis
Cambridge
C Morgan
Tue 20 08:45
OC3.3
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Risk of diabetes, cancer, large vessel disease and mortality in young women with polycystic ovary syndrome: a retrospective databased analysis
S Morgan
Tue 20 14:15
OC4.2
Oral Communications 4: Steroids
Age-dependent increase in the expression/activity of 11β-HSD1 in key metabolic tissues may underpin the ageing phenotype, notably sarcopenia
M Morris
Wed 21 10:00
N1.2
Nurses' Session 1:
Thyroid Eye Disease
Z Mughal
Manchester, UK
Tue 20 15:30
S7.4
Symposium 7: LATITUDE: ENDOCRINE CONSEQUENCES OF HUMAN MIGRATION
Resurgence of vitamin D deficiency rickets in the UK
Manchester, UK
S Myint
Wed 21 13:45
N2.1
Nurses' Session 2:
Conn's and phaeochromocytoma
R Nadif
Mon 19 17:00
OC2.5
Oral Communications 2: REPRODUCTION AND BONE
Nutrient regulation of growth factor signalling in human placenta
K Newbold
Mon 19 15:00
S4.4
Symposium 4: ADVANCES IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER
Novel treatments - from PCR to patient
S Ozanne
Wed 21 09:00
S9.1
Symposium 9: DEVELOPMENTAL PROGRAMMING OF ENDOCRINE DISEASE
Developmental programming of type 2 diabetes
U Ozcan
Boston, USA
Mon 19 11:30
S2.2
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
ER stress, leptin signalling and obesity
Boston, USA
S Parajes
Mon 19 15:00
OC1.7
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Progressive adrenal insufficiency and 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene
S Pearce
Newcastle, UK
Tue 20 09:15
OC3.5
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Steroidogenic function following B lymphocyte depletion therapy in new onset autoimmune Addison's disease
Newcastle, UK
Thu 22 11:30
CM4.4
Clinical Management Workshop 4: HOW DO I APPROACH...
Endocrine evaluation in a patient with coeliac disease
Newcastle, UK
B Pedersen
Copenhagen, Denmark
Mon 19 16:00
S5.1
Symposium 5: SPRINT OR MARATHON? MUSCLING IN ON THE OLYMPICS
Muscles and their myokines
Copenhagen, Denmark
N Peel
Tue 20 08:15
CM2.1
Clinical Management Workshop 2: CONTROVERSIES IN AETIOLOGY AND MANAGEMENT OF OSTEOPOROSIS
Impact of lifestyle choices on skeletal health
J Pickup
Mon 19 14:50
AP1.3
Applied Physiology Workshop:
Nanomedicine in clinical diabetes
D Pinato
Tue 20 17:30
OC5.5
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
Role of the hypoxic signalling pathways in the histopathological prediction of malignancy in phaeochromocytomas and paragangliomas
Professor Nelly Pitteloud
Lausanne, Switzerland
Thu 22 10:30
CM3.1
Clinical Management Workshop 3: ADVANCES IN ASSESSMENT AND MANAGEMENT OF INFERTILITY
Novel mutations causing infertility
Lausanne, Switzerland
P-F Plouin
Paris, France
Wed 21 10:30
S10.4
Symposium 10:
Novel therapies for malignant phaeochromocytomas and paragangliomas
Paris, France
M Poy
Berlin, Germany
Tue 20 17:30
S8.3
Symposium 8: SMALL MOLECULES, BIG EFFECTS: THE EMERGING ROLE FOR MICRO RNAS
MicroRNA and the beta-cell
Berlin, Germany
S Rahman
Mon 19 17:30
S5.4
Symposium 5: SPRINT OR MARATHON? MUSCLING IN ON THE OLYMPICS
Mitochondrial dysfunction and muscle disease
T Raivio
Helsinki, Finland
Mon 19 12:30
S3.4
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Can testosterone therapy be stopped in some hypogonadal patients?
Helsinki, Finland
M Read
Tue 20 10:00
OC3.8
Oral Communications 3: OBESITY, THYROID AND ADDISON'S DISEASE
Dietary factors augment the ability of the proto-oncogene PBF to induce goitrogenesis and hyperplasia in vivo
M Reincke
Wed 21 14:45
S11.3
Symposium 11: NOVEL LESSONS FROM MINERALOCORTICOID EXCESS
Long term consequences of primary hyperaldosteronism
P Richards
Mon 19 13:30
S4.1
Symposium 4: ADVANCES IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER
Can imaging predict malignancy in a thyroid nodule?
D Ron
Mon 19 11:00
S2.1
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
ER stress and metabolic regulation
R Ross
Thu 22 08:30
PL8
CLINICAL ENDOCRINOLOGY TRUST MEDAL LECTURE
Developing growth hormone agonists and antagonists for the clinic
M Sadeq
Tue 20 15:45
OC4.8
Oral Communications 4: Steroids
The role of a novel co-regulator in modifying the transcriptional activities of the glucocorticoid receptor
K Sakamoto
Mon 19 17:00
S5.3
Symposium 5: SPRINT OR MARATHON? MUSCLING IN ON THE OLYMPICS
Novel signalling mechanisms controlling glycogen homeostasis in muscle
J Saleh
Tue 20 18:00
OC5.7
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
The role of the familialpituitary adenoma gene, AIP, in the proliferative and invasive activity of a malignant pancreatic cell line
M Santoro
Naples, Italy
Wed 21 13:45
S12.1
Symposium 12: MEDULLARY THYROID CANCER
Molecular pathogenesis of MTC
Naples, Italy
P Sassone-Corsi
Irvine, USA
Tue 20 18:40
PL3
SOCIETY FOR ENDOCRINOLOGY TRANSATLANTIC MEDAL
Metabolism to epigenetics: the circadian clock link
Irvine, USA
M Schlumberger
Paris, France
Wed 21 15:15
S12.4
Symposium 12: MEDULLARY THYROID CANCER
Novel targeted therapies for MTC
Paris, France
N Schoenmakers
Mon 19 14:30
OC1.5
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation
S Shalet
Thu 22 11:20
SE1.3
SENIOR ENDOCRINOLOGISTS' SESSION
UK stance on adult GH replacment maintains our isolation from Europe
M Sheppard
Wed 21 12:00
PL5
SOCIETY FOR ENDOCRINOLOGY JUBILEE MEDAL LECTURE
Acromegaly - improving outcomes
P Southern
Mon 19 13:30
AP1.1
Applied Physiology Workshop:
Magnetic nanoparticles for drug delivery
T Stephenson
Mon 19 14:00
S4.2
Symposium 4: ADVANCES IN THE MANAGEMENT OF DIFFERENTIATED THYROID CANCER
Predictive value of cytology and molecular markers in thyroid cancer
A Stevens
Tue 20 16:45
OC5.2
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
A network analysis of gene expression through childhood highlights changes related to age and growth
Professor Roland Stimson
Edinburgh, UK
Mon 19 18:40
YEP1.2
YOUNG ENDOCRINOLOGISTS' PRIZE LECTURES
Quantifying in vivo extra-adrenal cortisol production and dysregulation in human metabolic disease
Edinburgh, UK
C Sze
Tue 20 17:00
OC5.3
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
Long term experience of 131I-MIBG therapy in the treatment of neuroendocrine tumours: has it improved survival and what are the long term sequelae?
Dr Abd Tahrani
Birmingham, UK
Tue 20 14:30
YE1.2
Young Endocrinologists' Symposium: OBTAINING FUNDING AND NETWORKING FOR YOUNG ENDOCRINOLOGISTS
Pathways in clinical academia, fellowships and networking
Birmingham, UK
A Taylor
Tue 20 17:15
OC5.4
Oral Communications 5: GROWTH, TUMOURS AND PITUITARY
Steroid metabolomics in adrenocortical carcinoma reveal mitotane as an inducer of CYP3A4 and an inhibitor of 5alpha-reductase activity with major implications for drug metabolism and hydrocortisone replacement
Raj Thakker
Oxford, United Kingdom
Mon 19 11:00
S1.1
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Genetic models of pituitary disease in MEN1
Oxford, United Kingdom
Thu 22 09:30
FO1.1
Funding opportunities: NIHR/MRC Efficacy and Mechanisms Evaluations (EME) Board
Opportunities in translational research - the NIHR/MRC Efficacy and Mechanisms Evaluations (EME) Board
Oxford, United Kingdom
M Thomas
Tue 20 14:00
S7.1
Symposium 7: LATITUDE: ENDOCRINE CONSEQUENCES OF HUMAN MIGRATION
The origins and evolution of lactase persistence
I Thompson
Tue 20 15:00
YE1.3
Young Endocrinologists' Symposium: OBTAINING FUNDING AND NETWORKING FOR YOUNG ENDOCRINOLOGISTS
Career opportunities in the States
V Thornton-Jones
Wed 21 15:00
N2.4
Nurses' Session 2:
Day-to-day practice on management of steroid replacement
A Tiganescu
Tue 20 14:00
OC4.1
Oral Communications 4: Steroids
Increased 11β-hydroxysteroid dehydrogenase type 1 activity is associated with the adverse expression of glucocorticoid target genes in ageing human skin
H Timmers
Nijmegen, The Netherlands
Wed 21 10:00
S10.3
Symposium 10:
Laboratory assessment and diagnostic imaging
Nijmegen, The Netherlands
A Toogood
Mon 19 16:30
CM1.2
Clinical Management Workshop 1: THE LATE CONSEQUENCES OF CANCER THERAPY IN ADULTS
The impact of cancer treatment on pituitary function
C Toumpanakis
Thu 22 07:30
MTE6
MEET THE EXPERT 6
Prioritising therapy in neuroendocrine tumours
Thu 22 13:15
MTE6
MEET THE EXPERT 6 - REPEAT
Prioritising therapy in neuroendocrine tumours
G Trew
Thu 22 12:30
CM3.4
Clinical Management Workshop 3: ADVANCES IN ASSESSMENT AND MANAGEMENT OF INFERTILITY
The endocrine basis of what we do in the IVF clinic
M Vanderpump
Tue 20 07:15
MTE2
MEET THE EXPERT 2
Amiodarone
Tue 20 17:15
MTE2
MEET THE EXPERT 2 - REPEAT
Amiodarone
S Vohra
Mon 19 16:45
OC2.4
Oral Communications 2: REPRODUCTION AND BONE
ERβ and GPR30 mediate distinct and opposite oestrogenic influences on microglial phagocytosis of apoptotic neuronal cells
A Wagenmakers
Mon 19 16:30
S5.2
Symposium 5: SPRINT OR MARATHON? MUSCLING IN ON THE OLYMPICS
Exercise effects on fat metabolism and insulin sensitivity in human muscle
H Wallace
Mon 19 17:00
CM1.3
Clinical Management Workshop 1: THE LATE CONSEQUENCES OF CANCER THERAPY IN ADULTS
The impact of cancer treatment on fertility and pregnancy
R Warth
Regensburg, Germany
Wed 21 13:45
S11.1
Symposium 11: NOVEL LESSONS FROM MINERALOCORTICOID EXCESS
A difficult TASK: murine models of mineralocorticoid excess
Regensburg, Germany
J Wilding
Thu 22 09:45
FO1.2
Funding opportunities: NIHR/MRC Efficacy and Mechanisms Evaluations (EME) Board
NIHR research networks: an update
Thu 22 11:10
CM4.3
Clinical Management Workshop 4: HOW DO I APPROACH...
Neuroendocrine assessment in morbid obesity
P Williams
Mon 19 16:00
OC2.1
Oral Communications 2: REPRODUCTION AND BONE
The expression of kisspeptin and kisspeptin receptor is altered in pre-eclampsia
E Wilson
Chapel Hill, USA
Tue 20 09:45
S6.4
Symposium 6: INHIBITING STEROID ENZYMES TO TREAT COMMON DISEASE
Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone
Chapel Hill, USA
A Wren
Thu 22 10:50
CM4.2
Clinical Management Workshop 4: HOW DO I APPROACH...
Endocrine assessment in HIV/AIDS
F Wu
Mon 19 11:00
S3.1
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Is there a male menopause - lesson from the European Male Ageing Study
P Yeoh
Wed 21 14:15
N2.2
Nurses' Session 2:
Nursing case study on phaeochromocytoma
M Zennaro
Paris, France
Wed 21 14:15
S11.2
Symposium 11: NOVEL LESSONS FROM MINERALOCORTICOID EXCESS
Human potassium channel mutations and mineralocorticoid hypertension
Paris, France
A Zielinska
Tue 20 14:30
OC4.3
Oral Communications 4: Steroids
A hypomorphic H6PD allele is sufficient to rescue the skeletal myopathy but not the lack of 11β-HSd type-1 mediated glucocorticoid regeneration phenotypes of H6PDKO mice
Mon 19 11:00
S1.1
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Genetic models of pituitary disease in MEN1
Oxford, United Kingdom
Mon 19 11:30
S1.2
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Modelling pituitary tumours in zebrafish
Los Angeles, USA
Mon 19 12:00
S1.3
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Mouse model of craniopharyngioma
Mon 19 12:30
S1.4
Symposium 1: GENETIC REGULATION OF PITUITARY TUMOURIGENESIS
Molecular signatures of pituitary tumours
Mon 19 11:00
S2.1
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
ER stress and metabolic regulation
Mon 19 11:30
S2.2
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
ER stress, leptin signalling and obesity
Boston, USA
Mon 19 12:00
S2.3
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
Lipotoxic endoplasmic reticulum stress and pancreatic beta-cell demise in type 2 diabetes
Brussels, Belgium
Mon 19 12:30
S2.4
Symposium 2: ENDOPLASMIC RETICULUM STRESS IN METABOLIC DISEASE AND OBESITY
Patients with monogenic diabetes resulting from ER stress of the pancreatic beta-cell
Mon 19 11:00
S3.1
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Is there a male menopause - lesson from the European Male Ageing Study
Mon 19 11:30
S3.2
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Does testosterone treatment increase mortality in elderly men?
Boston, USA
Mon 19 12:00
S3.3
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
What is the best form of testosterone replacement?
Mon 19 12:30
S3.4
Symposium 3: TESTOSTERONE IN MEN: HOW LOW CAN YOU GO?
Can testosterone therapy be stopped in some hypogonadal patients?
Helsinki, Finland
Mon 19 13:00
LUNCH
HALL Q
Mon 19 13:30
AP1.1
Applied Physiology Workshop:
Magnetic nanoparticles for drug delivery
Mon 19 14:10
AP1.2
Applied Physiology Workshop:
Nanoparticles as imaging agents
St Louis, USA
Mon 19 14:50
AP1.3
Applied Physiology Workshop:
Nanomedicine in clinical diabetes
Mon 19 13:30
OC1.1
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Functional characterisation and translational clinical applications of kisspeptin-10
Mon 19 13:45
OC1.2
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Structure-function analysis of calcium-sensing receptor (CaSR) mutations reveal clustering at calcium binding sites of the extracellular bilobed venus flytrap domain
Mon 19 14:00
OC1.3
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Effect of selenium status on the skeleton in post-menopausal women: the OPUS study
Mon 19 14:15
OC1.4
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis
Cambridge
Mon 19 14:30
OC1.5
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation
Mon 19 14:45
OC1.6
Oral Communications 1: YOUNG ENDOCRINOLOGISTS' PRIZE SESSION
A homozygous glutathione peroxidase 1 mutation, p.Arg130-Leu133del, in a patient with familial glucocorticoid deficiency
Mon 19 15:00
OC1.7